top of page
Shuttle Pharmaceuticals (Nasdaq: SHPH) Enters into Manufacturing Agreement for Ropidoxuridine
Rockville, MD and Irvine, CA — September 22, 2022 – Boustead Securities, LLC (“Boustead”) client Shuttle Pharmaceuticals Holdings, Inc....
Boustead IPO Client Virax Biolabs Introduces Monkeypox Virus Antigen Rapid Test Kit
London & Irvine, CA, September 21, 2022 – Boustead Securities, LLC (Boustead) client Virax Biolabs ("Virax" or the "Company") (Nasdaq:...
Know Labs, Inc. Announces Closing of $8.28 Million Public Offering of Common Stock
Irvine, CA — September 20, 2022 – Boustead Securities, LLC (“Boustead”) client Know Labs, Inc. (NYSE: KNW), an emerging developer of...
Know Labs, Inc. Announces Pricing of Upsized $7.2 Million Public Offering of Common Stock
Irvine, CA — September 15, 2022 – Boustead Securities, LLC (“Boustead”) client Know Labs, Inc. (NYSE: KNW), an emerging developer of...
Boustead Client Know Labs, Inc. (KNWN) Announces NYSE American Listing Approval
Irvine, CA — September 15, 2022 – Boustead Securities, LLC (“Boustead”) client Know Labs, Inc. (OTCQB: KNWN), an emerging developer of...
bottom of page